JHS Svendgaard Board Approves Rs. 8.26 Crore Warrant Issue to Non-Promoters
JHS Svendgaard Retail Ventures Limited's board has approved the issuance of fully convertible warrants worth Rs. 8.26 crore to eight non-promoter investors at Rs. 25 per warrant, with Amit Sadh and Purnima Sharma receiving the largest allocations of 10 lakh warrants each. The company has scheduled an EGM for May 30, 2026, to seek shareholder approval, with warrants convertible within 18 months from allotment date.

*this image is generated using AI for illustrative purposes only.
JHS Svendgaard Retail Ventures Limited has announced board approval for a significant fundraising initiative through the issuance of fully convertible warrants worth Rs. 8.26 crore to non-promoter investors. The board meeting held on April 30, 2026, approved this preferential allotment as part of the company's capital expansion strategy, with the meeting commencing at 03:30 P.M. and concluding at 03:53 P.M.
Board Meeting Outcome and Regulatory Filing
The Board of Directors considered and approved the issue of fully convertible warrants to persons belonging to the non-promoter category on preferential basis, aggregating up to Rs. 8,26,25,000. The company has informed both BSE (Scrip Code: 544197) and NSE (Trading Symbol: RETAIL) about this corporate action in compliance with Regulation 30 of SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.
| Parameter: | Details |
|---|---|
| Total Issue Size: | Rs. 8,26,25,000 |
| Issue Price: | Rs. 25 per warrant |
| Face Value: | Rs. 10 |
| Premium: | Rs. 15 |
| Total Warrants: | 33,05,000 |
| Conversion Period: | 18 months from allotment |
| Nature of Consideration: | Cash |
Warrant Allocation Details
The warrants will be allocated among eight non-promoter investors as per the official regulatory filing. Amit Sadh and Purnima Sharma will receive the largest allocations of 10,00,000 warrants each, representing the majority stake in this preferential issue.
| Allottee Name: | Category | Warrants Allocated |
|---|---|---|
| Amit Sadh: | Non-Promoter | 10,00,000 |
| Purnima Sharma: | Non-Promoter | 10,00,000 |
| Sunny Bakshi: | Non-Promoter | 5,00,000 |
| Fresh Impact Labs Private Limited: | Non-Promoter | 4,00,000 |
| Vinita Gupta: | Non-Promoter | 2,00,000 |
| Ujjwal Anand: | Non-Promoter | 1,00,000 |
| Abhijeet Mohan Warang: | Non-Promoter | 1,00,000 |
| Nalin Kant Beura: | Non-Promoter | 5,000 |
Conversion Terms and Shareholder Approval
Each warrant carries the right exercisable by the warrant holder to subscribe to one equity share per warrant. The conversion can be exercised at any time within 18 months from the date of allotment, in one or more tranches at the option of the warrant holder. The warrants will convert into fully paid-up equity shares with a face value of Rs. 10 each.
The company has scheduled an Extraordinary General Meeting for Saturday, May 30, 2026, to seek necessary shareholder approval for the proposed preferential issue. The board approved convening this EGM as part of the regulatory compliance process.
Regulatory Compliance Framework
The warrant issue has been structured in accordance with the provisions of Chapter V of SEBI Issue of Capital and Disclosure Requirements Regulations, 2018, and applicable provisions of the Companies Act, 2013. The issue price of Rs. 25 per warrant has been determined by the Board of Directors in accordance with SEBI regulations, with consideration being made in cash.
The regulatory filing was digitally signed by Kuldeep Jangir, Company Secretary & Compliance Officer, and the information has been made available on the company website at www.jhsretail.com . The company operates under CIN: L52100HR2007PLC093324 and was formerly known as JHS Svendgaard Retail Ventures Private Limited.
Historical Stock Returns for JHS Svendgaard Retail Ventures
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +3.52% | +1.10% | +25.81% | -36.96% | -40.93% | -46.94% |
How will JHS Svendgaard utilize the Rs. 8.26 crore funds to drive its retail expansion strategy over the next 18 months?
What impact could the potential 33+ lakh new equity shares have on existing shareholders' ownership dilution if all warrants are converted?
Will the company's debt-to-equity ratio and financial leverage improve significantly following this capital infusion?

































